Statement of Financial Position (USD $)	Jun. 30, 2014	Mar. 31, 2014
Assets, Current
Cash and Cash Equivalents, at Carrying Value	$ 1,111,694	$ 1,873,141
Restricrted Cash, Current	94,917
Prepayments and Other Assets	64,909	20,390
Prepayment to Related Party for clinical trials	561,132
Assets, Current	1,832,652	1,893,531
Assets, Noncurrent
Finite-Lived Intangible Assets, Net	71,624	70,781
Restricted Cash, Noncurrent		85,462
Assets, Noncurrent	71,624	156,243
Assets	1,904,276	2,049,774
Liabilities, Current
Accounts Payable, Current	105,461	1,830
Other Liabilities, Current	10,376	6,844
Liabilities, Current	115,837	8,674
Liabilities, Noncurrent
Deferred Revenue and Credits, Noncurrent	1,687,800	1,667,200
Liabilities, Noncurrent	1,687,800	1,667,200
Liabilities	1,803,637	1,675,874
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Common Stock, Value, Issued	200,000	200,000
Additional Paid in Capital, Common Stock	2,924,672	2,924,672
Accumulated Other Comprehensive Income (Loss), Net of Tax	(12,893)	(8,882)
Retained Earnings (Accumulated Deficit)	(3,011,140)	(2,741,890)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	100,639	373,900
Liabilities and Equity	$ 1,904,276	$ 2,049,774